Supportive Care in Cancer

, Volume 22, Issue 5, pp 1409–1415 | Cite as

How long do the effects of acupuncture on hot flashes persist in cancer patients?

  • Jessica W. Frisk
  • Mats L. Hammar
  • Martin Ingvar
  • Anna-Clara E. Spetz Holm
Review Article

Abstract

Purpose

Acupuncture has been suggested as therapy for hot flashes in women with breast cancer and men with prostate cancer. In this systematic review, we sought to evaluate the long-term effects on vasomotor symptoms after the end of a defined treatment period of acupuncture in women with breast cancer and men with prostate cancer.

Methods

A literature search revealed 222 articles within the field. With defined exclusion criteria, we identified 17 studies. We also used the Jadad quality score and identified seven studies with a score of at least 3.

Results

Six of seven identified studies qualified for inclusion in an analysis that measured frequency of hot flashes weighted in relation to number of patients (n = 172). The average reduction from baseline to end of acupuncture (ranging between 5 and 12 weeks of treatment) showed 43.2 % reduction of hot flashes. At the last follow-up (mean 5.8 months, range 3–9 months) after the end of therapy, the weighted reduction from baseline was sustained at 45.6 % in the 153 of 172 patients (89 %) who were followed up.

Conclusions

Data from six prospective analyzed studies indicate at least 3-month effects after the end of acupuncture treatment for flashes in women with breast cancer and men with prostate cancer. However, larger randomized trials with long-term follow-up will be needed to confirm these preliminary findings.

Keywords

Acupuncture Breast neoplasm Prostatic cancer Hot flashes 

References

  1. 1.
    Avis NE, Ory M, Matthews KA et al (2003) Health-related quality of life in a multi-ethnic sample of middle-aged women: study of Women’s Health Across the Nation (SWAN). Med Care 41:1262–1276PubMedCrossRefGoogle Scholar
  2. 2.
    Spetz AC, Fredrikson MG, Hammar ML (2003) Hot flashes in a male population aged 55, 65, and 75 years, living in the community of Linkoping, Sweden. Menopause 10:81–87PubMedGoogle Scholar
  3. 3.
    Spetz AC, Palmefors L, Skobe S et al (2007) Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in a Swedish elderly population. Menopause 14:999–1005PubMedGoogle Scholar
  4. 4.
    Spetz Holm AC, Fredrikson MG, Theodorsson E et al (2011) Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism. Aging Male 14:249–256CrossRefGoogle Scholar
  5. 5.
    Buchholz N-P, Mattarelli G, Huber Buchholz MM (1994) Post-orchiectomy hot flashes. Eur Urol 266:120–122Google Scholar
  6. 6.
    Frödin T, Ålund G, Varenhorst E (1985) Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flashes after orchidectomy in patients with prostatic cancer. Prostate 7:203–208PubMedCrossRefGoogle Scholar
  7. 7.
    Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682–1691PubMedCrossRefGoogle Scholar
  8. 8.
    Harris PF, Remington PL, Trentham-Dietz A et al (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23:501–509PubMedCrossRefGoogle Scholar
  9. 9.
    Carpenter JS, Elam JL, Ridner SH et al (2004) Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31:591–598PubMedCrossRefGoogle Scholar
  10. 10.
    Savard J, Davidson JR, Ivers H et al (2004) The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27:513–522PubMedCrossRefGoogle Scholar
  11. 11.
    Love RR, Cameron L, Connell B et al (1991) Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 151:1842–1847PubMedCrossRefGoogle Scholar
  12. 12.
    Day R, Ganz PA, Costantino JP et al (1999) Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel project P-1 Study. J Clin Oncol 17:2659–2669PubMedGoogle Scholar
  13. 13.
    Crandall C, Petersen L, Ganz PA et al (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11:519–530PubMedCrossRefGoogle Scholar
  14. 14.
    MacLennan AH, Broadbent JL, Lester S, et al. (2004) Oral oestrogen and combined oestrogen/progestagen therapy versus placebo for hot flashes. Cochrane Database Syst Rev (4):CD002978Google Scholar
  15. 15.
    Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333CrossRefGoogle Scholar
  16. 16.
    Herrington DM, Vittinghoff E, Lin F et al (2002) Statin therapy, cardiovascular events and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 105:2962–2967PubMedCrossRefGoogle Scholar
  17. 17.
    Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427PubMedCrossRefGoogle Scholar
  18. 18.
    Holmberg L, Iversen OE, Rudenstam CM et al (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100:475–482PubMedCrossRefGoogle Scholar
  19. 19.
    Charig CR, Rundle JS (1989) Flashing: long-term side effect of orchiectomi in treatment of prostatic carcinoma. Urology 33:175–178PubMedCrossRefGoogle Scholar
  20. 20.
    Spetz AC, Hammar M, Lindberg B et al (2001) Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation in metastatic carcinoma of the prostate. J Urol 166:517–520PubMedCrossRefGoogle Scholar
  21. 21.
    Karling P, Hammar M, Varenhorst E (1994) Prevalence and duration of vasomotor symptoms after surgical or medical castration in men with prostatic carcinoma. J Urol 152:1170–1173PubMedGoogle Scholar
  22. 22.
    Kronenberg F, Fugh-Berman A (2002) Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 137:805–813PubMedCrossRefGoogle Scholar
  23. 23.
    North American Menopause Society (2004) Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 11:11–33CrossRefGoogle Scholar
  24. 24.
    Mom CH, Buijs C, Willemse PHB et al (2006) Hot flashes in breast cancer patients. Crit Rev Oncol Hematol 57:63–77PubMedCrossRefGoogle Scholar
  25. 25.
    Wong VC, Lim CE, Luo X et al (2009) Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 25:166–174PubMedCrossRefGoogle Scholar
  26. 26.
    Albertazzi P (2007) Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric 115–120. doi:10.1080/13697130701440980Google Scholar
  27. 27.
    Albertazzi P (2006) Noradrenergic andsertonergic modulation to treat vasomotor symptoms. J Br Menopause Soc 12:7–11PubMedCrossRefGoogle Scholar
  28. 28.
    Kenemans P, Bundred NJ, Foidart JM et al (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10:135–146PubMedCrossRefGoogle Scholar
  29. 29.
    Kelly CM, Juurlink DN, Gomes T et al (2010) Selective serotonin reuptake inhibitors and breastcancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 340:693–701CrossRefGoogle Scholar
  30. 30.
    Quella SK, Loprinzi CL, Sloan J et al (1999) Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 162:98–102PubMedCrossRefGoogle Scholar
  31. 31.
    Roth AJ, Scher HI (1998) Sertraline relieves hot flashes secondary to medical castrations as treatment of advanced prostate cancer. Psychooncology 7:129–132PubMedCrossRefGoogle Scholar
  32. 32.
    Loprinzi CL, Barton DL, Sloan JA et al (2008) Mayo clinic and north central cancer treatment group hot flash studies: a 20-year experience. Menopause 15:655–660PubMedCrossRefGoogle Scholar
  33. 33.
    Loprinzi CL, Michalak JC, Quella SK et al (1994) Megestrol acetate for the prevention of hot flashes. N Engl J Med 331:347–552PubMedCrossRefGoogle Scholar
  34. 34.
    Thacker H (2011) Assesing risks and benefits of non-hormonal treatments for vasomotor symptoms in perimenopausal women and postmenopausal women. J Womens Health 20:1007–1016CrossRefGoogle Scholar
  35. 35.
    Irani J, Salomon L, Oba R et al (2010) Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproteroneactetate for the treatment of vasomotor hot flashes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 11:147–154PubMedCrossRefGoogle Scholar
  36. 36.
    Frisk J (2010) Managing hot flashes in men after prostate cancer–a systematic review. Maturitas 65:15–22PubMedCrossRefGoogle Scholar
  37. 37.
    Andersson S, Lundeberg T (1995) Acupuncture—from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 45:271–281PubMedCrossRefGoogle Scholar
  38. 38.
    Wyon Y, Lindgren R, Lundeberg T et al (1995) Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal women. Menopause 2:3–12CrossRefGoogle Scholar
  39. 39.
    D’Amico JF, Greendale GA, Lu JK et al (1991) Induction of hypothalamic opoid activity with transdermal estradiol administration in postmenopausal women. Fertil Steril 55:754–758PubMedGoogle Scholar
  40. 40.
    Melis GB, Paoletti AM, Gambacciani M et al (1984) Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using Naloxone. Neuroendocrinology 39:60–63PubMedCrossRefGoogle Scholar
  41. 41.
    Nedstrand E, Wijma K, Wyon Y et al (2005) Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 8:243–250PubMedCrossRefGoogle Scholar
  42. 42.
    Cohen SM, Rosseau ME, Carey BL (2003) Can acupuncture relieve symptoms of the menopause? Holist Nurs Pract 17:295–299PubMedCrossRefGoogle Scholar
  43. 43.
    Porzio G, Trapasso T, Martelli S et al (2002) Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori 88:128–130PubMedGoogle Scholar
  44. 44.
    Nir Y, Huang MI, Schenyer R et al (2007) Acupuncture for postmenopausal hot flashes. Maturitas 56:383–395PubMedCrossRefGoogle Scholar
  45. 45.
    Frisk J, Carlhäll S, Källström A-C et al (2008) Long-term follow-up of acupuncture and hormone therapy on hot flashes in women with breast cancer: a prospective, randomized, controlled multicenter trial. Climacteric 11:166–174PubMedCrossRefGoogle Scholar
  46. 46.
    Hammar M, Frisk J, Grimås Ö et al (1999) Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J Urol 161:853–859PubMedCrossRefGoogle Scholar
  47. 47.
    Frisk J, Spetz AC, Hjertberg H et al (2009) Two modes of acupuncture as a treatment for hot flashes in men with prostate cancer-A prospective multicenter study with long-term follow-up. Eur Urol 55:156–163PubMedCrossRefGoogle Scholar
  48. 48.
    Ashmalla H, Jiang ML, Guirguis A et al (2011) Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy. Int J Radiat Oncol Biol Phys 79:1358–1363CrossRefGoogle Scholar
  49. 49.
    Baber R, Hickey M, Kwik M (2005) Therapy for menopausal symptoms during and after treatment for breast cancer: safety considerations. Drug Saf 28:1085–1100PubMedCrossRefGoogle Scholar
  50. 50.
    Streitberger K, Kleinhenz J (1998) Introducing a placebo needle into acupuncture research. Lancet 352:364–365PubMedCrossRefGoogle Scholar
  51. 51.
    Goddard G, Shen Y, Steele B et al (2005) A controlled trial of placebo versus real acupuncture. J Pain 6:237–242PubMedCrossRefGoogle Scholar
  52. 52.
    Park J, White A, Stevinson C, Ernst E et al (2002) Validating a new non-penetrating sham acupuncture device: two randomized controlled trials. Acupunct Med 20:168–171PubMedCrossRefGoogle Scholar
  53. 53.
    White P, Lewith G, Hopwood V et al (2003) The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial. Pain 106:401–409PubMedCrossRefGoogle Scholar
  54. 54.
    Tsukayama H, Yamashita H, Kimura T et al (2006) Factors that influence the applicability of sham needle in acupuncture trials: two randomized, single-blind, crossover trials with acupuncture-experienced subjects. Clin J Pain 22:346–349PubMedCrossRefGoogle Scholar
  55. 55.
    Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12PubMedCrossRefGoogle Scholar
  56. 56.
    Deng VA, Yeung S et al (2007) Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol 25:5584–5590PubMedCrossRefGoogle Scholar
  57. 57.
    Hervik J, Mjåland O (2009) Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial. Breast Cancer Res Treat 116:311–316PubMedCrossRefGoogle Scholar
  58. 58.
    Liljegren A, Gunnarsson P, Landgren BM et al (2012) Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial. Breast Cancer Res Treat 135:791–798PubMedCrossRefGoogle Scholar
  59. 59.
    Tukmachi E (2000) Treatment of hot flashes in breast cancer patients with acupuncture. Acupunct Med 18:22–27CrossRefGoogle Scholar
  60. 60.
    Filshie J, Bolton T, Browne D et al (2005) Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients-audit and treatment algorithm. Acupunct Med 23:171–180PubMedCrossRefGoogle Scholar
  61. 61.
    Walker G, de Valois B, Davies R et al (2007) Ear acupuncture for hot flashes—the perceptions of women with breast cancer. Complement Ther Clin Pract 14:250–257CrossRefGoogle Scholar
  62. 62.
    Harding C, Harris A, Chadwick D (2008) Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU 103:186–190CrossRefGoogle Scholar
  63. 63.
    Beer T, Benavides M, Emmons S et al (2010) Acupuncture for hot flashes in patients with prostate cancer. Urology 76:1182–1188PubMedCentralPubMedCrossRefGoogle Scholar
  64. 64.
    de Valois BA, Young TE, Robinson N et al (2010) Using traditional acupuncture for breast cancer-related hot flashes and night sweats. J Altern Complement Med 16:1047–1057PubMedCrossRefGoogle Scholar
  65. 65.
    Walker E, Rodriguez A, Kohn B et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28:634–640PubMedCrossRefGoogle Scholar
  66. 66.
    Otte J, Carpenter J, Zhong X et al (2011) Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clin Nurse Spec 25:228–236PubMedCentralPubMedCrossRefGoogle Scholar
  67. 67.
    Bokmand S, Flyger H (2013) Acupuncture relieves menopausal discomfort in breast cancer patients: a prospective, double blinded, randomized study. Breast 22:320–323PubMedCrossRefGoogle Scholar
  68. 68.
    Huang W, Pach D, Napadow V et al (2012) Characterizing acupuncture stimuli using brain imaging with fMRI—a systematic review and meta-analysis of the literature. PLoS ONE 7(4):e32960. doi:10.1371/journal.pone.0032960 PubMedCentralPubMedCrossRefGoogle Scholar
  69. 69.
    Freedman R (1989) Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 26:573–579PubMedCrossRefGoogle Scholar
  70. 70.
    Cohen FJ, Lu Y (2000) Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas 34:65–73PubMedCrossRefGoogle Scholar
  71. 71.
    Mao JJ, Leed R, Bowman MA et al (2012) Acupuncture for hot flashes: decision making by breast cancer susvivors. J Am Board Fam Med 25:323–332PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Jessica W. Frisk
    • 1
    • 2
  • Mats L. Hammar
    • 1
  • Martin Ingvar
    • 3
  • Anna-Clara E. Spetz Holm
    • 1
    • 4
  1. 1.Division of Obstetrics and Gynecology, Department of Clinical and Experimental MedicineLinköping UniversityLinköpingSweden
  2. 2.Clinical Department of Surgery, VHN, County Council ÖstergötlandLinköping UniversityLinköpingSweden
  3. 3.Osher Center for Intergrative Medicine, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
  4. 4.Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Faculty of Health SciencesUniversity Hospital of LinköpingLinköpingSweden

Personalised recommendations